Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biotime Inc (BTX)

2.35 -0.03 (-1.26%)

04-20 16:00

Open:

2.38

Pre. Close:

2.38

High:

2.43

Low:

2.32

Volume:

377,198

Market Cap:

298M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.434 - 2.451

2.451 - 2.464

Low:

2.276 - 2.299

2.299 - 2.316

Close:

2.309 - 2.339

2.339 - 2.363

Technical analysis  (as of: 2018-04-20 4:28:02 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.05     One year: 3.27

Support:

Support1: 2.30    Support2: 1.91

Resistance:

Resistance1: 2.61    Resistance2: 2.80

Pivot:

2.47

Moving Averages:

MA(5): 2.43     MA(20): 2.48

MA(100): 2.58     MA(250): 2.75

MACD:

MACD(12,26): -0.06     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 20.74     %D(3): 30.37

RSI:

RSI(14): 39.81

52-Week:

High: 3.5  Low: 2.1  Change(%): -26.9

Average Vol(K):

3-Month: 48892  10-Days 24984

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BTX has closed above bottom band by 13.7%. Bollinger Bands are 22.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-16T07:00:00-04:00
Data from BioTime's OpRegen® and Retinal Restoration Programs to Be Presented at ARVO 2018

2018-04-09T08:00:00-04:00
Data from BioTime's OpRegen® Program to Be Presented at the Fifth Annual Retinal Cell and Gene Therapy Innovation Summit

2018-04-09T07:30:00-04:00
BioTime, Inc.: An Undervalued Regenerative Medicine Company

2018-03-27T07:00:00-04:00
BioTime Announces Cash Sale of Ascendance Biotechnology

2018-03-15T22:52:06-04:00
BioTime's (BTX) CEO Adi Mohantyon Q4 2017 Results - Earnings Call Transcript

2018-03-15T16:11:06-04:00
BioTime EPS of -$0.58

2018-03-15T16:05:00-04:00
BioTime Reports Fourth Quarter and Fiscal 2017 Results

2018-03-13T08:25:30-04:00
BioTime submits CE mark application for European approval of Renevia

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

126.87

Shares Float (M)

112.99

% Held by Insiders

10.90

% Held by Institutions

46.90

Shares Short (K)

8259

Shares Short Prior Month (K)

6770

Stock Financials

EPS

-0.260

EPS Est. Current Year

0.150

EPS Est. Next Year

-0.290

EPS Est. Next Quarter

-0.080

Forward EPS

-0.270

Book Value (p.s.)

1.940

PEG Ratio

Profit Margin

Operating Margin

-1175.71

Return on Assets (ttm)

-12.6

Return on Equity (ttm)

-14.2

Qtrly Rev. Growth

-7.8

Gross Profit (p.s.)

0.018

Sales Per Share

EBITDA (p.s.)

-0.226

Qtrly Earnings Growth

Operating Cash Flow (M)

-30.52

Levered Free Cash Flow (M)

-22.11

atoplab.com

Valuation

P/E

-9.00

P/E Growth Ratio

-0.02

P/BV

1.21

P/S

9895860224.00

P/CF

-9.73

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.